指南与共识腹部CTMR

探索新版京都胰腺囊性病变管理指南:概述及与既往指南的比较

Exploring the new Kyoto guidelines for managing pancreatic cysts: an overview and comparison with previous guidelines.
指南 / 共识 · Abdom Radiol (NY) · 2024-11-29

本文回顾并比较六部主要指南(2015 AGA、2017 IAP/Fukuoka、2017 ACR、2018 ACG、2018 欧洲研究组及2024京都指南),总结其在危险因素、监测方案和手术转诊标准上的关键差异,重点阐述2024京都指南的更新及近期研究进展的意义。

要点

  • CT报告胰腺囊性病变检出率1.2-2.6%,MRI为2.4-49.1%。
  • 主胰管型IPMN较分支胰管型更易见高级别异型增生或浸润癌。
  • 2024京都指南为最新版,与既往五部指南在监测与手术指征上存在差异。

核心结论

  • 2024京都指南为最新版胰腺囊性病变管理指南,与既往五部指南在危险因素、监测方案和手术转诊标准上存在关键差异。

研究设计与样本

  • 综述类文章,回顾并比较六部指南:2015美国胃肠病学会指南、2017国际胰腺病学会(IAP/Fukuoka)指南、2017美国放射学会指南、2018美国胃肠病学会指南、2018欧洲研究组指南及2024京都指南。

诊断标准与关键数值

  • CT报告胰腺囊性病变检出率为1.2-2.6%,MRI为2.4-49.1%。
  • 主胰管型IPMN较分支胰管型IPMN更可能见高级别异型增生或浸润癌。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The rising use of diagnostic imaging has led to an increase in the incidental detection of pancreatic cysts, with reported incidences of 1.2-2.6% on Computed Tomography and 2.4-49.1% on Magnetic Resonance Imaging. While many of these cysts are asymptomatic and benign, the enhanced imaging techniques have also revealed malignant and premalignant lesions. Mucinous neoplasms, including intraductal papillary mucinous neoplasms (IPMNs) and mucinous cystic neoplasms, are particularly concerning due to their potential for malignant transformation. Recent studies highlight significant variations in dysplasia across IPMN types, with main duct IPMNs showing a higher likelihood of high-grade dysplasia or invasive carcinoma compared to branch duct IPMNs. Management and follow-up of these lesions remain controversial due to inconsistent guidelines. This article reviews and compares six major guidelines: the 2015 American Gastroenterological Association guidelines, the 2017 International Association of Pancreatology (IAP/Fukuoka) guidelines, the 2017 American College of Radiology guidelines, the 2018 American College of Gastroenterology guidelines, the 2018 European Study Group guidelines, and the newly released, 2024 Kyoto guidelines. We summarize key differences in risk factors, surveillance protocols, and surgical referral criteria, with a focus on the updated 2024 Kyoto guidelines and the implications of recent research advancements.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Rahmatullah ZF, Nia IY, Afghani E, et al. Exploring the new Kyoto guidelines for managing pancreatic cysts: an overview and comparison with previous guidelines. Abdom Radiol (NY). 2024. PMID: 39611939. doi:10.1007/s00261-024-04665-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。